ACLOVATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aclovate, and when can generic versions of Aclovate launch?
Aclovate is a drug marketed by Fougera Pharms and is included in two NDAs.
The generic ingredient in ACLOVATE is alclometasone dipropionate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aclovate
A generic version of ACLOVATE was approved as alclometasone dipropionate by TARO on July 29th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACLOVATE?
- What are the global sales for ACLOVATE?
- What is Average Wholesale Price for ACLOVATE?
Summary for ACLOVATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Patent Applications: | 3,749 |
| DailyMed Link: | ACLOVATE at DailyMed |
US Patents and Regulatory Information for ACLOVATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | ACLOVATE | alclometasone dipropionate | CREAM;TOPICAL | 018707-001 | Dec 14, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fougera Pharms | ACLOVATE | alclometasone dipropionate | OINTMENT;TOPICAL | 018702-001 | Dec 14, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACLOVATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Fougera Pharms | ACLOVATE | alclometasone dipropionate | CREAM;TOPICAL | 018707-001 | Dec 14, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Fougera Pharms | ACLOVATE | alclometasone dipropionate | OINTMENT;TOPICAL | 018702-001 | Dec 14, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ACLOVATE
See the table below for patents covering ACLOVATE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Belgium | 862089 | ⤷ Sign Up | |
| Philippines | 18800 | NOVEL 7-HALO-3,20-DIOXO-1,4-PREGNADIENES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | ⤷ Sign Up |
| New Zealand | 186031 | 3,20-DIOXO-7ALPHA-HALO-4-PREGNENES AND-1,4-PREGNADINES | ⤷ Sign Up |
| Australia | 517326 | ⤷ Sign Up | |
| Singapore | 58683 | ⤷ Sign Up | |
| Portugal | 67432 | PROCESS FOR PREPARATION OF NOVEL 7-HALO-3,20-DIOXO-1,4-PREGNADIENES AND-4-PREGNENES | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
